SCHEMBL26259526

SCHEMBL26259526

CC(C)(C)c1cc(-c2ccco2)c2ccccc2c1-c1ccco1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 5/20 0.36
▸ CDC25A P30304 1/20 0.35
▸ CDC25C P30307 1/20 0.35
▸ CTSV O60911 1/20 0.35
▸ CTSL P07711 1/20 0.35
▸ IMPDH2 P12268 1/20 0.34
▸ IMPDH1 P20839 1/20 0.34
▸ ALDH1A1 P00352 7/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ KDM4E B2RXH2 5/20 0.33
▸ POLB P06746 4/20 0.33
▸ TDP1 Q9NUW8 3/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ HPGD P15428 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ ALOX15 P16050 2/20 0.33
▸ CASP1 P29466 2/20 0.33
▸ PKM P14618 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26259540 0.87 IMPDH2 (0.34) CFTRIMPDH2IMPDH1ALDH1A1SMN1; SMN2
SCHEMBL26259656 0.83 MET (0.34) CFTRIMPDH2IMPDH1ALDH1A1SMN1; SMN2
SCHEMBL26259680 0.81 ALDH1A1 (0.38) ALDH1A1KDM4EPOLBTDP1HSD17B10
SCHEMBL26259393 0.78 ALDH1A1 (0.39) CFTRCDC25ACDC25CCTSVCTSL
SCHEMBL26259346 0.77 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2KDM4EPOLBTDP1
SCHEMBL22426573 0.75 ALDH1A1 (0.43) CFTRIMPDH2IMPDH1ALDH1A1SMN1; SMN2
SCHEMBL26259455 0.74 PLAU (0.49) IMPDH2IMPDH1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL28741710 0.74 ADORA2A (0.48) CTSVCTSLALDH1A1KDM4EPOLB
SCHEMBL26259920 0.73 ALDH1A1 (0.41) CFTRIMPDH2IMPDH1ALDH1A1SMN1; SMN2
SCHEMBL26259706 0.73 IMPDH2 (0.37) CFTRIMPDH2IMPDH1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 CFTR 4210/4885CDC25A 3193/4885CDC25C 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback